Dr. Vosganian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 Seaport Blvd
Redwood City, CA 94063- Is this information wrong?
Education & Training
- Scripps Clinic/Scripps Green HospitalFellowship, Hematology and Medical Oncology, 2008 - 2011
- University of California Davis HealthResidency, Internal Medicine, 2005 - 2008
- Virginia Commonwealth University School of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2006 - 2026
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 5 citationsFirst-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.Antoine Italiano, Philippe A. Cassier, Chia-Chi Lin, Tuomo Alanko, K. Peltola, Anas Gazzah, Her Shyong Shiah, Emiliano Calvo, Andrés Cervantes, Desamparados Roda, Dieg...> ;Cancer Immunology, Immunotherapy. 2021 Jul 3
- 5 citationsModel Informed Dosing Regimen and Phase I Results of the Anti-PD-1 Antibody Budigalimab (ABBV-181).John D. Powderly, Alexander I. Spira, Shunsuke Kondo, Toshihiko Doi, Jason J. Luke, Drew W. Rasco, Bo Gao, Minna Tanner, Philippe A. Cassier, Anas Gazzah, Antoine Ital...> ;Clinical and Translational Science. 2021 Jan 1
- 8 citationsSafety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancer.Emiliano Calvo, Alexander I. Spira, Maria de Miguel, Shunsuke Kondo, Anas Gazzah, Michael Millward, Hans Prenen, Sylvie Rottey, Lydia Warburton, Tuomo Alanko, Philippe...> ;Cancer Treatment and Research Communications. 2021 Jan 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: